Mixed fortunes continue for Ionis rare disease drug inotersen
admin 19th May 2017 Uncategorised 0Meets its Phase III targets but concerns remain over its side effects profile
More: Mixed fortunes continue for Ionis rare disease drug inotersen
Source: News